Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cara Therapeutics, Inc. - Common Stock (NQ: CARA )

5.200 -0.400 (-7.14%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cara Therapeutics, Inc. - Common Stock

< Previous 1 2
...
10 11 12 13 14 15 16 17 Next >
Benzinga's Top Ratings Upgrades, Downgrades For March 8, 2023
Via Benzinga
Cannabis Stock Gainers And Losers From March 7, 2023
Via Benzinga
S&P 500 Down 1.5%; Dow Falls Over 550 Points
U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping around 450 points on Tuesday. The Dow traded down 1.68% to 32,868.40 while the NASDAQ fell 1.31% to 11,523.25. The S&P... 
Via Benzinga
Analyst Ratings for Cara Therapeutics
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Earnings Outlook For Cara Therapeutics
Via Benzinga
Cannabis Stock Movers For February 17, 2023
Via Benzinga
Cannabis Stock Movers For February 6, 2023
Via Benzinga
Why Rivian Automotive Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers Virax Biolabs Group Limited (NASDAQ: VRAX) jumped 99% to $1.3195 after the company announced an agreement for the distribution of an Avian Influenza A Virus real-time PCR test kit to the... 
Via Benzinga
Dow Tumbles 250 Points Following Powell's Comments; Crude Oil Down 2%
U.S. stocks traded lower midway through trading, with the Dow Jones dropping around 250 points on Tuesday. The Dow traded down 0.77% to 33,172.39 while the NASDAQ fell 0.72% to 11,591.36. The S&P 500... 
Via Benzinga
US Stocks Mixed Ahead Of Powell Testimony; Dick's Sporting Goods Posts Upbeat Earnings
U.S. stocks traded mixed this morning, with the Nasdaq Composite gaining around 20 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.03% to 33,420.92 while the NASDAQ rose... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Why Adial Pharmaceuticals Shares Are Trading Higher By Around 65%; Here Are 20 Stocks Moving Premarket
Gainers 
Via Benzinga
DocuSign To Rally Around 25%? Here Are 10 Other Analyst Forecasts For Tuesday
Wells Fargo cut the price target for Cheniere Energy, Inc. (NYSE: LNG) from $236 to $230. Wells Fargo analyst Michael Blum maintained an Overweight rating. Cheniere Energy shares fell 4.8% to close at... 
Via Benzinga
Cara Therapeutics Gets Price Targets Cuts By Analysts After Weak Q4 Results
Cara Therapeutics, Inc. (NASDAQ: CARA) posted downbeat Q4 results. Cara Therapeutics posted a Q4 loss of $0.56 per share, versus market expectations of $0.32 per share. The company’s quarterly sales... 
Via Benzinga
Nutanix, Cara Therapeutics, Tremor International And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
U.S. stock futures traded higher this morning. Here are some big stocks recording losses in today’s pre-market trading session. 
Via Benzinga
These 2 Stocks Are Plunging After Hours Monday
The market closed mixed, but these two companies gave investors some bad news. 
Via The Motley Fool
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Cara Therapeutics Announces Fourth Quarter and Full Year 2022 Financial Results
From Cara Therapeutics, Inc.
Via GlobeNewswire
Cannabis Stock Movers For March 3, 2023
Via Benzinga
Bearish Sentiment Across The Cannabis Space - Check Full Movers For February 21, 2023
Via Benzinga
Cara Therapeutics to Announce Fourth Quarter and Full Year 2022 Financial Results on March 6, 2023
From Cara Therapeutics, Inc.
Via GlobeNewswire
Bullish Sentiment Across The Cannabis Space - Check Full Movers For February 20, 2023
Via Benzinga
Cannabis Stock Movers For February 15, 2023
Via Benzinga
Cannabis Stock Gainers And Losers From February 14, 2023
Via Benzinga
Bullish Friday For Marijuana Stocks - iAnthus Capital Hldgs, Green Thumb Industries Among Top Gainers
Via Benzinga
Cara Therapeutics Announces Results from the KOMFORT Phase 2 Trial of Oral Difelikefalin for the Treatment of Pruritus in Notalgia Paresthetica Published in the New England Journal of Medicine
Publication underscores the importance of data in underrecognized neuropathic itch disorder which lacks an approved treatment 
From Cara Therapeutics, Inc.
Via GlobeNewswire
Bullish Tuesday For Marijuana Stocks - iAnthus Capital Hldgs, TerrAscend Among Top Gainers
Via Benzinga
Cannabis Stock Movers For January 30, 2023
Via Benzinga
Cannabis Stock Gainers And Losers From January 25, 2023
Via Benzinga
< Previous 1 2
...
10 11 12 13 14 15 16 17 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.